12.19.22
The Council for Responsible Nutrition (CRN) has announced that Tara Martin, general counsel of Nutrawise/YouTheory, will serve as the associations new board of directors chair beginning in January 2023.
Martin succeeds Barry Ritz, PhD, chief scientific officer and vice president, professional R&D and regulatory affairs at Nestlé Health Science. Ritz has served on the board for the past two years and will continue to serve on the board as its immediate past chair.
Martin has been employed at Nutrawise/YouTheory for the past six years, and has been a member of CRN’s board since 2019, most recently as its chair-elect. In her role at Nutrawise Health and Beauty Corporation, a manufacturer and distributor of supplements sold under the YouTheory brand, she provides strategic and day-to-day legal and business guidance to senior management and staff on a range of business and legal matters such as regulatory compliance, intellectual property, employment law, contract management, corporate governance and compliance, sales practices, and risk management and loss mitigation.
“We are pleased to announce Tara Martin’s tenure as CRN board of directors chair in 2023,” said CRN president and CEO Steve Mister. “As a board member, she has been essential in steering CRN decision making on critical issues affecting the dietary supplement and functional food industry. I look forward to working closely with her during the next two years. I also thank Barry for his leadership, particularly around the #Act4Access initiative, which raised awareness of how CRN members are actively working toward access to nutrition and nutrition education for all and helped mobilize more members in the fight against hunger.”
Other elected officers of the board are:
CRN’s executive committee members will include: Aaron Bartz, Ortho Molecular; Aaron Bennett, Vytalogy; Christine Burdick-Bell, Pharmavite; Eric Choban, DSM; Mike Finamore, Gemini Pharmaceutical; Jennifer Holahan, Haleon; Lisa Pankiewicz, Clorox; Michelle Stout, Amway; Karen Todd, Kyowa Hakko; and Mike Yatcilla, PhD, Herbalife Nutrition.
CRN members elected five new members to its board of directors. These include two members from the finished products segment: Doug Brown, vice president, Americas, Sirio Nutrition Co. Ltd., and Andrew Shao, PhD, senior vice president, global scientific and regulatory affairs, Chromadex.
Two new members from the ingredient supplier segment are Justin Green, PhD, director of scientific affairs at Embria Health Sciences; John Helfrick, director of human nutrition, BASF Corp., and Deshanie Rai, PhD, vice president, global scientific and regulatory affairs, OmniActive Health Technologies. All were elected to three-year terms.
“We are looking forward to the contributions of Doug, Andrew, Justin, John and Deshanie on the Board,” Mister said. “CRN has an ambitious program of work as we continue to advance a more favorable climate for our members to develop, source, manufacture, and market science-backed products for better health and nutrition. Our Board plays a critical role in developing and guiding that agenda.”
Martin succeeds Barry Ritz, PhD, chief scientific officer and vice president, professional R&D and regulatory affairs at Nestlé Health Science. Ritz has served on the board for the past two years and will continue to serve on the board as its immediate past chair.
Martin has been employed at Nutrawise/YouTheory for the past six years, and has been a member of CRN’s board since 2019, most recently as its chair-elect. In her role at Nutrawise Health and Beauty Corporation, a manufacturer and distributor of supplements sold under the YouTheory brand, she provides strategic and day-to-day legal and business guidance to senior management and staff on a range of business and legal matters such as regulatory compliance, intellectual property, employment law, contract management, corporate governance and compliance, sales practices, and risk management and loss mitigation.
“We are pleased to announce Tara Martin’s tenure as CRN board of directors chair in 2023,” said CRN president and CEO Steve Mister. “As a board member, she has been essential in steering CRN decision making on critical issues affecting the dietary supplement and functional food industry. I look forward to working closely with her during the next two years. I also thank Barry for his leadership, particularly around the #Act4Access initiative, which raised awareness of how CRN members are actively working toward access to nutrition and nutrition education for all and helped mobilize more members in the fight against hunger.”
Other elected officers of the board are:
- Bruce Brown, vice president and general manager, nutrition and supplements, Kerry (chair elect)
- Mandy Kraynik, vice president, innovation, Nature’s Way (treasurer)
- Mark Walsh, CEO, MeriCal (secretary)
- Barry Ritz, PhD, Nestlé Health Science (immediate past chair)
- Harvey Kamil, Piping Rock (Chair Emeritus)
CRN’s executive committee members will include: Aaron Bartz, Ortho Molecular; Aaron Bennett, Vytalogy; Christine Burdick-Bell, Pharmavite; Eric Choban, DSM; Mike Finamore, Gemini Pharmaceutical; Jennifer Holahan, Haleon; Lisa Pankiewicz, Clorox; Michelle Stout, Amway; Karen Todd, Kyowa Hakko; and Mike Yatcilla, PhD, Herbalife Nutrition.
CRN members elected five new members to its board of directors. These include two members from the finished products segment: Doug Brown, vice president, Americas, Sirio Nutrition Co. Ltd., and Andrew Shao, PhD, senior vice president, global scientific and regulatory affairs, Chromadex.
Two new members from the ingredient supplier segment are Justin Green, PhD, director of scientific affairs at Embria Health Sciences; John Helfrick, director of human nutrition, BASF Corp., and Deshanie Rai, PhD, vice president, global scientific and regulatory affairs, OmniActive Health Technologies. All were elected to three-year terms.
“We are looking forward to the contributions of Doug, Andrew, Justin, John and Deshanie on the Board,” Mister said. “CRN has an ambitious program of work as we continue to advance a more favorable climate for our members to develop, source, manufacture, and market science-backed products for better health and nutrition. Our Board plays a critical role in developing and guiding that agenda.”
